focus -WSS

focus

author：fashion 2025-09-27 12:57:01 - browse：933

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Positive childhood experiences can help future health

WSS

Hospitals use virtual reality to design more inclusive rooms for kids

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

In venture capital firm's success, lessons for turning crisis into profit

Intermittent fasting comes with a heart risk? Not so fast

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Plastic surgeons increase patient psychiatric screenings

focus

focus

hotspot

In Memoriam: Notable people who died in 2023

AstraZeneca to buy developer of next

Walensky prepares to leave CDC — and Congress — behind

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

The cancer drug shortage isn’t new — and neither are the solutions

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Cancer drug shortages should be causing more outrage

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Medicare details structure of new drug price negotiation program

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

hotspot

SCOTUS questions limit to govt efforts to fight misinformation

Creating egg and sperm cells from stem cells raises ethical issues

Wegovy cuts risk of cardiovascular events by 20%, study finds

‘The Bear’ and hospitality in hospitals

Leading voice in opioid treatment defends methadone clinic system

Hospitals use virtual reality to design more inclusive rooms for kids

explore

focus

hotspot

entertainment